These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1387346)
1. Augmented plasma protein C activity after coronary thrombolysis with urokinase in patients with acute myocardial infarction. Goto S; Handa S; Kawai Y; Watanabe K; Abe S; Takahashi E; Hori S; Ikeda Y Cardiology; 1992; 80(3-4):252-6. PubMed ID: 1387346 [TBL] [Abstract][Full Text] [Related]
2. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
3. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction. Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005 [TBL] [Abstract][Full Text] [Related]
4. Procoagulant effects of thrombolytic therapy in acute myocardial infarction. Wang Y; Liu Q; Zhu J; Yuan Z; Ma X Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883 [TBL] [Abstract][Full Text] [Related]
5. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Gulba DC; Barthels M; Westhoff-Bleck M; Jost S; Rafflenbeul W; Daniel WG; Hecker H; Lichtlen PR Circulation; 1991 Mar; 83(3):937-44. PubMed ID: 1900225 [TBL] [Abstract][Full Text] [Related]
6. Association of plasma levels of activated protein C with recanalization of the infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction. Takazoe K; Ogawa H; Yasue H; Sakamoto T; Oshima S; Arai H; Moriyama Y; Shimomura H; Hirai N; Kaikita K; Soejima H; Misumi K; Hosoda K Thromb Res; 1999 Jul; 95(1):37-47. PubMed ID: 10403685 [TBL] [Abstract][Full Text] [Related]
8. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase]. Bai XJ; Chen CX; He YL Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371 [TBL] [Abstract][Full Text] [Related]
9. Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction. Nordt TK; Moser M; Kohler B; Ruef J; Peter K; Kübler W; Bode C Thromb Haemost; 1998 Dec; 80(6):881-6. PubMed ID: 9869154 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of saruplase, an unglycosylated single-chain urokinase-type plasminogen activator, in patients with acute myocardial infarction. Koster RW; Cohen AF; Hopkins GR; Beier H; Günzler WA; van der Wouw PA Thromb Haemost; 1994 Nov; 72(5):740-4. PubMed ID: 7534946 [TBL] [Abstract][Full Text] [Related]
11. Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. Merlini PA; Bauer KA; Oltrona L; Ardissino D; Spinola A; Cattaneo M; Broccolino M; Mannucci PM; Rosenberg RD J Am Coll Cardiol; 1995 Jan; 25(1):203-9. PubMed ID: 7798503 [TBL] [Abstract][Full Text] [Related]
12. [Serial changes in hemostatic molecular markers after urokinase therapy of acute myocardial infarction]. Goto S; Kawai Y; Watanabe K; Hori S; Abe S; Handa S; Ikeda Y Kokyu To Junkan; 1992 Jan; 40(1):89-95. PubMed ID: 1532665 [TBL] [Abstract][Full Text] [Related]
13. Plasma resistance to activated protein C regulates the activation of coagulation induced by thrombolysis in patients with ischaemic heart disease. Pedersen OD; Gram J; Jespersen J Heart; 1997 Feb; 77(2):122-7. PubMed ID: 9068393 [TBL] [Abstract][Full Text] [Related]
14. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors. Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363 [TBL] [Abstract][Full Text] [Related]
15. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration. Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824 [TBL] [Abstract][Full Text] [Related]
17. Protein S and protein C anticoagulant activity in acute and chronic cardiac ischemic syndromes. Relationship to inflammation, complement activation and in vivo thrombin activity. D'Angelo A; Gerosa S; D'Angelo SV; Mailhac A; Colombo A; Agazzi A; Mazzola G; Chierchia S Thromb Res; 1994 Jul; 75(2):133-42. PubMed ID: 7974387 [TBL] [Abstract][Full Text] [Related]
18. [A primary report on thrombolytic therapy of acute myocardial infarction in 40 cases]. Hu D Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Jun; 19(3):143-4, 196. PubMed ID: 1914852 [TBL] [Abstract][Full Text] [Related]
19. [Intravenous thrombolysis with domestic urokinase in 40 cases of acute myocardial infarction]. Zhang XK; Li ND; Liu CH Zhonghua Nei Ke Za Zhi; 1993 Oct; 32(10):679-81. PubMed ID: 8156839 [TBL] [Abstract][Full Text] [Related]
20. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction. Tanigawa M; Wada H; Minamikawa K; Wakita Y; Nagaya S; Mori T; Tamaki S; Nishikawa H; Kakuta Y; Nakano T Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]